Put Them in Cells and Find Out
22 Jul 2014

So, when you put some diverse small molecules into cellular assays, how many proteins are they really hitting? You may know a primary target or two that they're likely to interact with, or (if you're doing phenotypic screening), you may not have any idea at all. But how many proteins (or other targets) are there that bind small molecules at all? 
 This is a question that many people are interested in, but hard data to answer it are not easily obtained. There have been theoretical estimates (https://www.science.org/pipeline/2013/05/22/how_many_binding_pockets_are_there) via several techniques (https://www.science.org/pipeline/2014/06/04/predicting_new_targets_another_approach) , but (understandably) not too much experimental evidence. Now comes this paper (http://pubs.acs.org/doi/abs/10.1021/ja505517t) from Ben Cravatt's group, and it's one of the best attempts yet. 
 What they've done is to produce a library of compounds, via Ugi chemistry (http://en.wikipedia.org/wiki/Ugi_reaction) , containing both a photoaffinity handle and an alkyne (for later "click" tagging). They'd done something similar before (http://pubs.acs.org/doi/abs/10.1021/ja304213w) , but the photoaffinity group in that case was a benzophenone, which is rather hefty. This time they used a diazirine, which is both small and the precursor to a very reactive carbene once it's irradiated. (My impression is that the diazirine is the first thing to try if you're doing photoaffinity work, for just those reasons). They made a small set of fairly diverse compounds (about 60), with no particular structural biases in mind, and set out to see what these things would label. 
 They treated PC-3 cells (human prostate-cancer derived) with each member of the library at 10 ÂµM, then hit them with UV to do the photoaffinity reaction, labeled with a fluorescent tag via the alkyne, and fished for proteins. What they found was a pretty wide variety, all right, but not in the nonselective shotgun style. Most compounds showed distinct patterns of protein labeling, and most proteins picked out distinct SAR from the compound set. They picked out six members of the library for close study, and found that these labeled about 24 proteins (one compound only picked up one target, while the most promiscuous compound labeled nine). What's really interesting is that only about half of these were known to have any small-molecule ligands at all. There were proteins from a number of different classes, and some (9 out of 24) weren't even enzymes, but rather scaffolding and signaling proteins (which wouldn't be expected to have many small-molecule binding possibilities). 
 A closer look at non-labeled versions of the probe compounds versus more highly purified proteins confirmed that the compounds really are binding as expected (in some cases, a bit better than the non-photoaffinity versions, in some cases worse). So even as small a probe as a diazirine is not silent, which is just what medicinal chemists would have anticipated. (Heck, even a single methyl or fluoro isn't always silent, and a good thing, too). But overall, what this study suggests is that most small molecules are going to hit a number of proteins (1 up to a dozen?) in any given cell with pretty good affinity. It also (encouragingly) suggests that there are more small-molecule binding sites than you'd think, with proteins that have not evolved for ligand responses still showing the ability to pick things up. 
 There was another interesting thing that turned up: while none of the Ugi compounds was a nonselective grab-everything compound, some of the proteins were . A subset of proteins tended to pick up a wide variety of the non-clickable probe compounds, and appear to be strong, promiscuous binders. Medicinal chemists already know a few of these things - CYP metabolizing enzymes, serum albumin, and so on. This post (https://www.science.org/pipeline/2014/06/25/wheres_the_widest_variety_of_chemical_matter) has some other suggestions. But there are plenty more of them out there, unguessable ones that we don't know about yet (in this case, PTGR and VDAC (http://en.wikipedia.org/wiki/Voltage-dependent_anion_channel) subtypes, along with NAMPT (http://en.wikipedia.org/wiki/Nicotinamide_phosphoribosyltransferase) ). There's a lot to find out.